News

Filter

Gilead partners to provide low-cost emtricitabine-based ARVs in developing countries

03-08-2012

Gilead Sciences (Nasdaq: GILD), together with Mylan Laboratories, Ranbaxy Laboratories and Strides Arcolab…

Anti-viralsBiotechnologyEmtricitabineGilead SciencesGlobalLicensingMylan LaboratoriesPharmaceuticalPricingProductionRanbaxy LaboratoriesStrides Arcolab

COMPANY SPOTLIGHT

Menarini

Back to top